DMAC icon

DiaMedica Therapeutics

15 hedge funds and large institutions have $3.91M invested in DiaMedica Therapeutics in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 5 closing their positions.

Holders
15
Holders Change
-2
Holders Change %
-11.76%
% of All Funds
0.3%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
4
Reduced
2
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
MHP
1
Manatuck Hill Partners
Connecticut
$1.32M 272,400
GPCM
2
Granite Point Capital Management
Massachusetts
$1.1M 227,230
WVP
3
Worth Venture Partners
New Jersey
$593K 122,156 -19,645 -14%
Vanguard Group
4
Vanguard Group
Pennsylvania
$393K 81,055
Millennium Management
5
Millennium Management
New York
$160K 32,963 -37,956 -54%
BlackRock
6
BlackRock
New York
$156K 32,053 +6,441 +25%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$85K 17,557 +2,158 +14%
William Blair & Company
8
William Blair & Company
Illinois
$49K 10,000 +10,000 New
FDCDDQ
9
Federation des caisses Desjardins du Quebec
Quebec, Canada
$28.1K 5,800 +5,800 New
PFGIA
10
Patriot Financial Group Insurance Agency
Massachusetts
$13K 2,750 +750 +38%
Royal Bank of Canada
11
Royal Bank of Canada
Ontario, Canada
$11K 2,347 +151 +7%
Bank of Montreal
12
Bank of Montreal
Ontario, Canada
$2K 310
GCM
13
Gables Capital Management
Florida
$1K 125
WC
14
Wexford Capital
Florida
-88,860 Closed
SCM
15
Stonepine Capital Management
Oregon
-13,705 Closed
Commonwealth Equity Services
16
Commonwealth Equity Services
Massachusetts
-13,277 Closed
UBS Group
17
UBS Group
Switzerland
-2,354 Closed
Bank of America
18
Bank of America
North Carolina
-211 Closed
CFGS
19
Concourse Financial Group Securities
Alabama
Toronto Dominion Bank
20
Toronto Dominion Bank
Ontario, Canada
$0 24
Deutsche Bank
21
Deutsche Bank
Germany
$0 17 +17 New